▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #26 by analyst upside · 2026-09-27
CALC
CalciMedica, Inc.
Healthcare · Market Cap $12M · P/E 0x
ANALYST PRICE TARGET
+2757.1%
implied upside to consensus target
Current Price $1.75
Consensus Target $50.0
Bull Target $75.0
Bear Target $30.0
Analysts Covering 3
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
2
Hold
1
Sell
0
52-Week Low $1.63
52-Week High $36.0
YTD Return -94.8%
FUNDAMENTALS
Market Cap $12M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-6.85
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $1.63
52-Week High $36.0
Current Price $1.75
Bear Target $30.0
Bull Target $75.0
● Now $1.75 ● Target $50.0
TRADING DATA
Avg Volume 87K
YTD Return -94.8%
Analyst Count 3
Consensus Buy
Upside to Target +2757.1%
Last Updated 2026-09-27

ANALYST SUMMARY

CalciMedica, Inc. (CALC) is currently trading at $1.75 with a Wall Street consensus price target of $50.0, implying potential upside of 2757.1% over the next 12 months. 3 analysts currently cover CALC, with a consensus rating of Buy - 67% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $75.0, while the most cautious has a target of $30.0.

CALC operates in the Healthcare sector with a market capitalisation of $12M. The stock is down 94.8% year-to-date and is currently trading near the lower end of its 52-week range of $1.63 – $36.0.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CALC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Guggenheim ● Initiated
Buy 2026-08-20 62% win rate (8 calls)
Oppenheimer - Reiterated
Outperform → Outperform 2026-03-05 14% win rate (7 calls)
HC Wainwright & Co. ↓ Downgrade
Buy → Neutral 2026-01-29 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-05-15 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-04-01 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-03-04 31% win rate (48 calls)
LUCID CAPITAL MARKETS ● Initiated
Buy 2024-12-17 40% win rate (5 calls)
HC Wainwright & Co. reit
Buy → Buy 2024-11-14 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
25
out of 100
Coverage depth
11/30
Consensus clarity
0/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →